Diagnostic criteria for schwannomatosis

Neurology

Volumn 64, Issue 11, 2005, Pages 1838-1845

  MacCollin, Mia ^a,k   Chiocca, E A ^b   Evans, D G ^c   Friedman, J M ^d   Horvitz, R ^e   Jaramillo, D ^j   Lev, M ^a   Mautner, V F ^f   Niimura, M ^g   Plotkin, S R ^a   Sang, C N ^h   Stemmer Rachamimov, A ^a   Roach, E S ⁱ  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^c ST MARY S HOSPITAL   (United Kingdom)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e National Neurofibromatosis Foundation   (United States)

^f UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^g Rinshoiyaku Inc   (Japan)

^h BRIGHAM AND WOMEN S HOSPITAL   (United States)

ⁱ WAKE FOREST SCHOOL OF MEDICINE   (United States)

^j CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^k Bldg 149 ^*  (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; DEXTROMETHORPHAN; GABAPENTIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OXCARBAZEPINE; SHORT ACTING DRUG; SODIUM CHANNEL BLOCKING AGENT; TOPIRAMATE;

CANCER DIAGNOSIS; CANCER GROWTH; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER SURGERY; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FAMILIAL DISEASE; GENETIC COUNSELING; GENETIC PREDISPOSITION; HUMAN; MOLECULAR BIOLOGY; NERVE SHEATH TUMOR; NEURILEMOMA; NEUROFIBROMATOSIS; NEUROIMAGING; PAIN; PAIN ASSESSMENT; PRIORITY JOURNAL; REVIEW; SCHWANNOMATOSIS; TREATMENT INDICATION; TUMOR GROWTH;

DIAGNOSIS, DIFFERENTIAL; HUMANS; NEURILEMMOMA; NEUROFIBROMATOSIS 2; NEUROMA, ACOUSTIC;

EID: 20444406794     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000163982.78900.AD     Document Type: Review

References (35)

1. MacCollin M, Woodfin W, Kronn D, Short MP. Schwannomatosis: a clinical and pathologic study. Neurology 1996;46:1072-1079.
2. Evans DGR, Huson SM, Ponder M, Strachan T, Harding A. Spinal and cutaneous Schwannomatosis is a variant form of type 2 neurofibromatosis. J Neurol Neurosurg Psychiatry 1997;62:361-366.
3. Antinheimo J, Sankila R, Carpen O, Pukkala E, Sainio M, Jaaskelainen J. Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas. Neurology 2000;54:71-76.
4. Ogose A, Hotta T, Hatano H, et al. Presacral multiple cellular schwannomas. Spine 2003;28:E426-429.
5. Kaufman DL, Heinrich BS, Willett C, et al. Somatic instability of the NF2 gene in Schwannomatosis. Arch Neurol 2003;60:1317-1320.
6. Seppala MT, Sainio MA, Haltia MJ, Kinnunen JJ, Setala KH, Jaaskelainen JE. Multiple schwannomas: Schwannomatosis or neurofibromatosis type 2? J Neurosurg 1998;89:36-41.
7. Leverkus M, Kluwe L, Roll EM, et al. Multiple unilateral schwannomas: segmental neurofibromatosis type 2 or Schwannomatosis? Br J Dermatol 2003;148:804-809.
8. Yamamoto T, Maruyama S, Mizuno K. Schwannomatosis of the sciatic nerve. Skeletal Radiol 2001;30:109-113.
9. Gorlin RJ, Koutlas IG. Multiple schwannomas, multiple nevi, and multiple vaginal leiomyomas: a new dominant syndrome. Am J Med Genet 1998;78:76-81.
10. Tanabe K, Tada K, Ninomiya H. Multiple schwannomas in the radial nerve. J Hand Surg [Br] 1997;22:664-666.
11. Shin KH, Moon SH, Suh JS, Jahng JS. Multiple neurilemomas. A case report. Clin Orthop 1998;357:171-175.
12. Pandit SK, Rattan KN, Gupta U, et al. Multiple neurilemmomas of the penis. Pediatr Surg Int 2000;16:457.
13. Shishiba T, Niimura M, Ohtsuka F, Tsuru N. Multiple cutaneous neurilemmomas as a skin manifestation of neurilemmomatosis. J Am Acad Dermatol 1984;10:744-754.
14. Purcell SM, Dixon SL. Schwannomatosis. An unusual variant of neurofibromatosis or a distinct clinical entity? Arch Dermatol 1989;125:390-393.
15. Ahn JY, Kwon SO, Shin MS, Shim JY, Kirn OJ. A case of multiple schwannomas of the trigeminal nerves, acoustic nerves, lower cranial nerves, brachial plexuses and spinal canal: Schwannomatosis or neurofibromatosis? Yonsei Med J 2002;43:109-113.
16. Ogose A, Hotta T, Morita T, Otsuka H, Hirata Y. Multiple schwannomas in the peripheral nerves. J Bone Joint Surg Br 1998;80:657-661.
17. Huang JH, Simon SL, Nagpal S, Nelson PT, Zager EL. Management of patients with Schwannomatosis: report of six cases and review of the literature. Surg Neurol 2004;62:353-361.
18. Rongioletti F, Drago F, Rebora A. Multiple cutaneous plexiform schwannomas with tumors of the central nervous system. Arch Dermatol 1989;125:431-432.
19. Ishida T, Kuroda M, Motoi T, Oka T, Imamura T, Machinami R. Phenotypic diversity of neurofibromatosis 2: association with plexiform schwannoma. Histopathology 1998;32:264-270.
20. MacCollin M, Willett C, Heinrich B, et al. Familial Schwannomatosis: exclusion of the NF2 locus as the germline event. Neurology 2003;60:1968-1674.
21. Ogihara S, Seichi A, Iwasaki M, et al. Concurrent spinal schwannomas and meningiomas. Case illustration. J Neurosurg 2003;98:300.
22. Jacoby LB, Jones D, Davis K, et al. Molecular analysis of the NF2 tumor-suppressor gene in Schwannomatosis. Am J Hum Genet 1997;61:1293-1302.
23. Evans DGR, Wallace A, Strachan T. Mosaicism in classical neurofibromatosis type 2: a common mechanism for sporadic disease in tumor prone syndromes? Am J Hum Genet 1998;63:727-736.
24. Moyhuddin A, Baser ME, Watson C, et al. Somatic mosaicism in neurofibromatosis 2: prevalence and risk of disease transmission to offspring. J Med Genet 2003;40:459-463.
25. Evans DG, Sainio M, Baser ME. Neurofibromatosis type 2. J Med Genet 2000;37:897-904.
26. MacCollin M, Ramesh V, Jacoby L, et al. Mutational analysis of patients with neurofibromatosis type 2. Am J Hum Genet 1994;55:314-320.
27. Scheithauer BW, Woodruff JM, Erlandson RA. Schwannoma. In: Atlas of tumor pathology, tumors of the peripheral nervous system. Third series, fascicle 24. Armed Forces Institute of Pathology, 1999;105-176.
28. Kirschner LS, Carney JA, Pack SD, et al. Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex. Nat Genet 2000;26:89-92.
29. Evans DG, Huson SM, Donnai D, et al. A genetic study of type 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity. J Med Genet 1992;29:841-846.
30. Jacoby LB, MacCollin M, Barone R, Ramesh V, Gusella JF. Frequency and distribution of NF2 mutations in schwannomas. Genes Chromosomes Cancer 1996;17:45-55.
31. Stemmer-Rachamimov AO, Xu L, Gonzalez-Agosti C, et al. Universal absence of Merlin, but not other ERM family members, in schwannomas. Am J Pathol 1997;151:1649-1654.
32. Blakley P, Louis DN, Short MP, MacCollin M. A clinical study of patients with multiple isolated neurofibromas. J Med Genet 2001;38:485-488.
33. Sobel RA. Vestibular (acoustic) schwannomas: histologic features in neurofibromatosis 2 and in unilateral cases. J Neuropathol Exp Neurol 1993;52:106-113.
34. Gutmann DH, Aylsworth A, Carey JC, et al. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 1997;278:51-57.
35. Baser ME, Friedman JM, Aeschliman D, et al. Predictors of the risk of mortality in neurofibromatosis 2. Am J Hum Genet 2002;71:715-723.